University of Newcastle: Pneumonia Risk Signals Potential for Precision Medicine
July 07, 2022
July 07, 2022
CALLAGHAN, Australia, July 7 (TNSjou) -- The University of Newcastle issued the following news:
The largest ever genomic study of pneumonia has identified the genetic risk signals of the disease, paving the way for potential new treatments and the use of precision medicine.
Precision medicine is a treatment approach that takes into account individual variability in genes, environment, and lifestyle for each person, allowing doctors and researchers to predict more accura . . .
The largest ever genomic study of pneumonia has identified the genetic risk signals of the disease, paving the way for potential new treatments and the use of precision medicine.
Precision medicine is a treatment approach that takes into account individual variability in genes, environment, and lifestyle for each person, allowing doctors and researchers to predict more accura . . .